146 related articles for article (PubMed ID: 2439344)
1. A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck.
Abele R; Honegger HP; Grossenbacher R; Mermillod B; Kaplan E; Gervasi A; Wolfensberger M; Lehmann W; Cavalli F
Eur J Cancer Clin Oncol; 1987 Jan; 23(1):47-53. PubMed ID: 2439344
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group.
Clavel M; Vermorken JB; Cognetti F; Cappelaere P; de Mulder PH; Schornagel JH; Tueni EA; Verweij J; Wildiers J; Clerico M
Ann Oncol; 1994 Jul; 5(6):521-6. PubMed ID: 7522527
[TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
Amrein PC; Fabian RL
Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
Clavel M; Cognetti F; Dodion P; Wildiers J; Rosso R; Rossi A; Gignoux B; Van Rymenant M; Cortes-Funes H; Dalesio O
Cancer; 1987 Sep; 60(6):1173-7. PubMed ID: 2441836
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy with methotrexate, bleomycin and hydroxyurea with or without cisplatin in advanced squamous cell carcinoma of the head and neck: a study of the Swiss Group for Clinical Cancer Research (SAKK).
Abele R; Honegger HP; Wolfensberger M; Grossenbacher R; Mermillod B; Cavalli F
Prog Clin Biol Res; 1985; 201():169-75. PubMed ID: 2419916
[No Abstract] [Full Text] [Related]
6. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
[TBL] [Abstract][Full Text] [Related]
7. Therapy of recurrent squamous cell carcinoma of the head and neck using combination vincristine, bleomycin, and methotrexate. A Southwest Oncology Group Study.
Smith RE; Heilbrun LK; Bottomley RM; Gad-el-Mawla N; Fletcher W
Cancer; 1986 Dec; 58(11):2382-5. PubMed ID: 2429754
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea fails to improve the results of MBD chemotherapy in cancer of the head and neck, but reduces toxicity.
Vogl SE; Camacho F; Kaplan BH; Lerner H; Cinberg J
Cancer; 1983 Dec; 52(11):2011-6. PubMed ID: 6194873
[TBL] [Abstract][Full Text] [Related]
9. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
[TBL] [Abstract][Full Text] [Related]
10. A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer.
Vogl SE; Schoenfeld DA; Kaplan BH; Lerner HJ; Engstrom PF; Horton J
Cancer; 1985 Aug; 56(3):432-42. PubMed ID: 2408735
[TBL] [Abstract][Full Text] [Related]
11. Vinorelbine, bleomycin and methotrexate as a salvage therapy for patients with head and neck squamous carcinoma in relapse after cisplatin/fluorouracil.
Iop A; Cartei G; Isaia A
Ann Oncol; 1998 Feb; 9(2):225-7. PubMed ID: 9553671
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer.
Cognetti F; Pinnarò P; Carlini P; Ruggeri EM; Ambesi Impiombato F; Del Vecchio MR; Giannarelli D; Perrino A
Cancer; 1988 Jul; 62(2):251-61. PubMed ID: 2454721
[TBL] [Abstract][Full Text] [Related]
13. Sequential methotrexate, 5-fluorouracil, and cisplatin in the treatment of recurrent squamous-cell carcinoma of the head and neck: failure of hypertonic saline to reduce the nephrotoxicity of cisplatin.
Dimery IW; Legha SS
J Clin Oncol; 1986 Nov; 4(11):1670-6. PubMed ID: 3095503
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinoma.
Tellez-Bernal E; Belehradek M; Recondo G; Cvitkovic E; Leridant AM; Vericel R; Armand JP
Am J Clin Oncol; 1990 Oct; 13(5):452-4. PubMed ID: 1699403
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy with cisplatinum, 5-fluorouracil, bleomycin, mitomycin C and hydroxyurea for previously untreated locally advanced squamous cell carcinomas of the head and neck.
Fountzilas G; Nicolaou A; Sridhar K; Sideras T; Haritanti A; Anastasakis C; Delis V; Vritsios A; Daniilidis J
Arch Otorhinolaryngol; 1989; 246(5):373-7. PubMed ID: 2480104
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
[TBL] [Abstract][Full Text] [Related]
18. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study.
Jacobs C; Meyers F; Hendrickson C; Kohler M; Carter S
Cancer; 1983 Nov; 52(9):1563-9. PubMed ID: 6352004
[TBL] [Abstract][Full Text] [Related]
19. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
